INS and Insulin resistance: Metformin, an insulin sensitizer widely used for treating type-2 diabetes mellitus, is employed in patients with polycystic ovary syndrome (PCOS) in light of the scientific data showing the pivotal role of insulin resistance in the pathogenesis of the syndrome, and of its beneficial effects on metabolism and ovulatory function in PCOS women [1].